drugset / Trial / NCT06654791
Mass Balance Clinical Trial of SIM0270
Phase 1
Active not recruiting
6 enrolled
Jiangsu Simcere Pharmaceutical Co., Ltd.
Nanjing Zaiming Pharmaceutical Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, non-randomized, open-label, single-cohort, single-dose phase I clinical study in healthy Chinese adult male subjects.
Timeline
- Start
- 2024-10-17
- Primary completion
- 2025-03-31
- Completion
- 2025-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SIM0270 | Unknown | — | Oral |
Indications
No indication recorded.